ECSP12012358A - SOLUBLE CYCLING GUANILATE ACTIVATORS - Google Patents
SOLUBLE CYCLING GUANILATE ACTIVATORSInfo
- Publication number
- ECSP12012358A ECSP12012358A ECSP12012358A ECSP12012358A EC SP12012358 A ECSP12012358 A EC SP12012358A EC SP12012358 A ECSP12012358 A EC SP12012358A EC SP12012358 A ECSP12012358 A EC SP12012358A
- Authority
- EC
- Ecuador
- Prior art keywords
- formula
- pharmaceutically acceptable
- acceptable salt
- guanilate
- activators
- Prior art date
Links
- 239000012190 activator Substances 0.000 title 1
- 230000001351 cycling effect Effects 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- ZOOGRGPOEVQQDX-KHLHZJAASA-N cyclic guanosine monophosphate Chemical compound C([C@H]1O2)O[P@](O)(=O)O[C@@H]1[C@H](O)[C@H]2N1C(N=C(NC2=O)N)=C2N=C1 ZOOGRGPOEVQQDX-KHLHZJAASA-N 0.000 abstract 3
- 150000003839 salts Chemical class 0.000 abstract 3
- 201000010099 disease Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 2
- 238000011321 prophylaxis Methods 0.000 abstract 2
- 238000002560 therapeutic procedure Methods 0.000 abstract 2
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 229940127557 pharmaceutical product Drugs 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Abstract
Un compuesto de fórmula I o una sal farmacéuticamente aceptable de la misma, son capaces de modular la producción del cuerpo del guanosín monofosfato cíclico (GMPc) y son generalmente adecuados para la terapia y profilaxis de las enfermedades que están asociadas con un equilibrio perturbado del GMPc. La invención se refiere además a los procesos para preparar compuestos de fórmula I o una sal farmacéuticamente aceptable del mismo, para su uso en la terapia y profilaxis de las enfermedades arriba mencionadas y para la preparación de productos farmacéuticos destinados a este fin, y a preparaciones farmacéuticas que comprendan compuestos de Fórmula I o una sal farmacéuticamente aceptable de los mismos.A compound of formula I or a pharmaceutically acceptable salt thereof, are capable of modulating the body production of cyclic guanosine monophosphate (cGMP) and are generally suitable for the therapy and prophylaxis of diseases that are associated with a disturbed cGMP balance. . The invention further relates to the processes for preparing compounds of formula I or a pharmaceutically acceptable salt thereof, for use in the therapy and prophylaxis of the above-mentioned diseases and for the preparation of pharmaceutical products intended for this purpose, and to pharmaceutical preparations. comprising compounds of Formula I or a pharmaceutically acceptable salt thereof.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US6134910A | 2010-05-27 | 2010-05-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP12012358A true ECSP12012358A (en) | 2013-01-31 |
Family
ID=52634062
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP12012358 ECSP12012358A (en) | 2010-05-27 | 2012-12-26 | SOLUBLE CYCLING GUANILATE ACTIVATORS |
Country Status (1)
| Country | Link |
|---|---|
| EC (1) | ECSP12012358A (en) |
-
2012
- 2012-12-26 EC ECSP12012358 patent/ECSP12012358A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DOP2012000300A (en) | SOLUBLE CYCLASE GUANILATE ACTIVATORS | |
| DOP2018000153A (en) | DERIVATIVES OF 4-AMINO-2- (1H-PIRAZOLO [3,4-B] PIRIDINA-3-IL) -6-OXO-6,7-DIHIDRO-5H-PIRROLO [2,3-D] PYRIMIDINE AND RESPECTIVES DERIVATIVES OF (1H-INDAZOL-3-IL) AS CGMP MODULATORS FOR THE TREATMENT OF CARDIOVASCULAR DISEASES | |
| MX2018005708A (en) | COMPOSITE OF 7- (TIAZOL-5-IL) PIRROLOPIRIMIDINE AS A TLR7 AGONIST. | |
| MX2017006649A (en) | Triazolo-pyrazinyl derivatives useful as soluble guanylate cyclase activators. | |
| MX2017002028A (en) | Pyrrolopyrimidine compounds used as tlr7 agonist. | |
| GT201400009A (en) | 4-IMIDAZOPIRIDAZIN-1-IL-BENZAMIDAS AND 4-IMIDAZOTRIAZIN-1-IL-BENZAMIDAS AS BTK INHIBITORS | |
| CR20130560A (en) | BEZOTIAZOL COMPOUNDS AND THEIR PHARMACEUTICAL USE | |
| DOP2011000264A (en) | AMINOTETRALINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND THEIR USES IN THERAPY | |
| UY33491A (en) | ? Sulfonamide derivatives and their pharmaceutically acceptable salts for use in medicine ?. | |
| CO6251364A2 (en) | DERIVATIVES OF MORFOLINO PIRIMIDINA USED IN DISEASES RELATED TO MTOR QUINASA AND / OR P13K | |
| MX373713B (en) | PYRAZOLOPYRIMIDINE COMPOUNDS. | |
| EA201490653A1 (en) | DERIVATIVES ESTRA-1,3,5 (10), 16-TETRAEN-3-CARBOXAMIDE, METHOD FOR THEIR PRODUCTION CONTAINING THEIR PHARMACEUTICAL PREPARATIONS | |
| DOP2015000005A (en) | DERIVATIVES OF ESTRA 1,3,5 (10), 16 TETRAENE 3 SUBSTITUTES, METHODS FOR THEIR PREPARATION, PHARMACEUTICAL PREPARATIONS CONTAINING THEM, AS WELL AS THEIR USE FOR THE PREPARATION OF MEDICINES | |
| NZ721780A (en) | Heterocyclic modulators of lipid synthesis for use against cancer and viral infections | |
| NI201800071A (en) | ISOINDOL COMPOUNDS | |
| MX2020003732A (en) | FUSIONED RING DERIVATIVE AS AN A2A RECEPTOR INHIBITOR. | |
| UY33745A (en) | DIFENYLAMINE DERIVATIVES: USES, SYNTHESIS PROCEDURE AND PHARMACEUTICAL COMPOSITIONS | |
| MX377004B (en) | 2,3-DIHYDRO-THIAZOLO[3,2-A]PYRIDIN-5-ONE DERIVATIVES, INTERMEDIARIES THEREOF, AND THEIR USE AS ANTIBACTERIAL AGENTS. | |
| ECSP12012358A (en) | SOLUBLE CYCLING GUANILATE ACTIVATORS | |
| CR20150092A (en) | USEFUL DIAZEPINONE DERIVATIVES FOR THE TREATMENT OF FRAGILE X SYNDROME, PARKINSON'S DISEASE OR REFLUX DISEASE | |
| UY33806A (en) | NOVEDOUS IMIDAZOQUINOLINE COMPOUNDS, COMPOSITIONS THAT CONTAIN THEM AND THEIR USE IN THE TREATMENT OF DISEASES MEDIATED BY TLR7? | |
| CU20100003A7 (en) | PIRIMIDINE TRISUSTITUTE DERIVATIVES FOR THE TREATMENT OF PROLIFERATIVE DISEASES | |
| CU20100004A7 (en) | PYRIMIDINE MORFOLINE DERIVATIVES USED IN DISEASES RELATED TO MTOR QUINASA AND / OR PI3K | |
| NI201400004A (en) | 4 - IMIDAZOPYRIDAZIN - 1 - IL - BENZAMIDES AND 4 - IMIDAZOTRIAZIN - 1 - IL - BENZAMIDES AS BTK INHIBITORS | |
| CU20100005A7 (en) | DERIVATIVES OF PIRIMIDINE TRISUSTITUIDA FOR THE TREATMENT OF PROLIFERATIVE DISEASES |